GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » Bioera SpA (MIL:BIE) » Definitions » EBIT

Bioera SpA (MIL:BIE) EBIT : €14.40 Mil (TTM As of Jun. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Bioera SpA EBIT?

Bioera SpA's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2024 was €15.01 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2024 was €14.40 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Bioera SpA's annualized ROC % for the quarter that ended in Jun. 2024 was 361.58%. Bioera SpA's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 3,239.72%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Bioera SpA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 380.43%.

Bioera SpA EBIT Historical Data

The historical data trend for Bioera SpA's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioera SpA EBIT Chart

Bioera SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.57 -5.42 15.69 -5.34 -3.45

Bioera SpA Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.11 -4.23 -2.84 -0.61 15.01

Competitive Comparison of Bioera SpA's EBIT

For the Conglomerates subindustry, Bioera SpA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioera SpA's EV-to-EBIT Distribution in the Conglomerates Industry

For the Conglomerates industry and Industrials sector, Bioera SpA's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Bioera SpA's EV-to-EBIT falls into.


Bioera SpA EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €14.40 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioera SpA  (MIL:BIE) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Bioera SpA's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

ROC % (Q: Jun. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Jun. 2024 ))/ count )
=30.112 * ( 1 - 0% )/( (10.353 + 6.303)/ 2 )
=30.112/8.328
=361.58 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3.846 - 10.999 - ( 0.067 - max(0, 19.052 - 1.546+0.067))
=10.353

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1.122 - 2.177 - ( 0.181 - max(0, 8.106 - 0.748+0.181))
=6.303

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Bioera SpA's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Jun. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=30.016/( ( (1.479 + max(-13.265, 0)) + (0.374 + max(-4.829, 0)) )/ 2 )
=30.016/( ( 1.479 + 0.374 )/ 2 )
=30.016/0.9265
=3,239.72 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.12 + 0.432 + 0.203) - (10.999 + 0 + 3.021)
=-13.265

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0.12) - (2.177 + 0 + 2.772)
=-4.829

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Bioera SpA's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2024 )
=14.403/3.786
=380.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioera SpA EBIT Related Terms

Thank you for viewing the detailed overview of Bioera SpA's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioera SpA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » Bioera SpA (MIL:BIE) » Definitions » EBIT
Comparable Companies
MIL:CLF MIL:PQ MIL:PTR MIL:GML MIL:GM MIL:ZUC MIL:IVN ADX:IHC HON TSE:6501 TSE:8001 MMM TSE:8058 TSE:8031 HKSE:00267 ADX:ALPHADHABI TSE:8002 TSE:8053 TSE:4901 HKSE:00001
Traded in Other Exchanges
B2A:Germany
Address
Via Pompeo Litta, 9, Milan, ITA, 20122
Website
http://www.bioera.it
Bioera SpA is engaged in the production and sale of natural and organic products in retail and wholesale distribution network. Its products include lactic ferments, fruit juices, oils, condiments, dietary supplements and cosmetics.

Bioera SpA Headlines

No Headlines